Elizabeth C. Heyes
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Journal: Nature communications
Published: November 02, 2022
Arrayed CRISPR/Cas9 Screening for the Functional Validation of Cancer Genetic Dependencies.
Journal: Bio-protocol
Published: August 20, 2022
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
Journal: Blood
Published: September 02, 2020
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.
Journal: Leukemia
Published: August 17, 2020
Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Journal: Nature structural & molecular biology
Published: November 07, 2019
Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia.
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: September 30, 2019
Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: June 21, 2019
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Journal: Leukemia
Published: August 02, 2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemia.
Journal: Leukemia
Published: September 12, 2017
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
Journal: Cell reports
Published: March 10, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026